Results for
"[search-keyword]"
Sponsor content
811 result(s) found, displaying 291 to 300
-
Prescription medicine decision summaryTGA decision: Bevacip/Bevaciptin (bevacizumab) is approved to treat various types of cancers.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DEXMEDETOMIDINE CIPLA dexmedetomidine (as hydrochloride) 200 microgram/2 mL concentrated injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DEXMED dexmedetomidine (as hydrochloride) 200 microgram/2 mL concentrated injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DEXEMCIP dexmedetomidine (as hydrochloride) 200 microgram/2 mL concentrated injection vial.
-
CIPLA MEDROXYPROGESTERONE medroxyprogesterone acetate 150 mg/1 mL injection suspension vial (318837)
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CIPLA MEDROXYPROGESTERONE medroxyprogesterone acetate 150 mg/1 mL injection suspension vial. -
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DEPROCIP medroxyprogesterone acetate 150 mg/1 mL injection suspension vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MEDPROCIP medroxyprogesterone acetate 150 mg/1 mL injection suspension vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for GEFTIRESS gefitinib 250 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for GEFTICIP gefitinib 250 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CIPLA GEFITINIB gefitinib 250 mg tablet blister pack.